| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | Turtle Cameron | See Remarks | Sale+OE | 2,000 | $37.28 | $74,564.20 | -16.9% | |
| Feb 10, 2020 | Homcy Charles J | Chairman Of Pharmaceuticals | Sell | 20,000 | $36.00 | $720,000.00 | -1.5% | |
| Feb 5, 2020 | Kumar Neil | CEO And President | Sell | 30,893 | $34.87 | $1,077,390.29 | -1.1% | |
| Feb 4, 2020 | Stephenson Brian C | See Remarks | Sell | 10,800 | $34.73 | $375,070.94 | -1.5% | |
| Feb 4, 2020 | Kumar Neil | See Remarks | Sell | 89,107 | $34.70 | $3,091,609.79 | -1.0% | |
| Feb 3, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 3,975 | $34.90 | $138,729.49 | -2.2% | |
| Jan 14, 2020 | Homcy Charles J | Chairman Of Pharmaceuticals | Sale+OE | 10,000 | $35.00 | $350,000.00 | -0.7% | |
| Jan 8, 2020 | Turtle Cameron | See Remarks | Sale+OE | 12,807 | $34.37 | $440,210.99 | -34.4% | |
| Jan 3, 2020 | Henderson Michael Thomas58 | See Remarks | Sell | 3,975 | $33.17 | $131,861.08 | -0.4% | |
| Jan 3, 2020 | Kumar Neil | See Remarks | Sell | 120,000 | $32.52 | $3,902,416.96 | -0.7% |